ANGLE plc has announced that Berenberg will act as the company's Nominated Adviser and Sole Broker with immediate effect. ANGLE is a liquid biopsy company that provides innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development, and clinical oncology. The company's FDA cleared and patent protected Parsortix® PC1 System enables complete downstream analysis of a blood sample, including whole cell imaging, proteomic analysis, and full genomic and transcriptomic molecular analysis. ANGLE's commercial businesses focus on diagnostic products and clinical services, including custom-made assay development and clinical trial testing for pharmaceutical companies.